Опубликовать статью

Информационное партнерство

Инфоресурсы

Контакты

«

Vol. 20, Art. 10 (pp. 94-109)    |    2019       

»

Short- and long-term bleeding complications after percutaneus coronary intervention in long-lived persons with acute coronary syndrome

Kurnikova E. A.1,2, Shenderov S. V.1, Dorofeev V. I. 1, Filippova O.I.1

1 City hospital 26, 2 Kostyushko str., Saint-Petersburg, 196247, Russian Federation, Tel.: +7(812)415-18-88; E-mail: b26@zdrav.spb.ru
2 Saint-Petersburg State Pediatric Medical University, 2 Litovskaya str, Saint-Petersburg, 194100, Russian Federation

Brief summary

Background. Bleeding is the widespread noncardiac complication after percutaneus coronary intervention. The aim this examination include the investigation of frequency and prediction capability hemorrhagic complications in short- end long-term time after percutaneus coronary intervention in long-lived patients with acute coronary syndrome Material and methods. This investigation includes retrospective analysis effect management of treatment acute coronary syndrome (PTCA vs conservative therapy) on frequency, time of development different types of bleeding complication in long-lived patients with acute coronary syndrome. Results. Short- end long-term bleeding are frequent complications in among long-lived patients with acute coronary syndrome undergoing primary percutaneous coronary intervention. The most patients experienced a BARC type ≤2 bleeding. The bleeding development et short-term period was connected with severity of acute heart failure (Killip III, IV), exertion fraction of left ventricle less than 40%, admission aPTT, pretreatment NOAC. Et long-term period diabetes mellitus and treatment by non-steroidal anti-inflammatory agent more than 5 days are associated with increasing the frequency of bleeding. The ACTION-GWTG is the most conclusive prognostic scale of bleeding in long-lived patients with acute coronary syndrome undergoing primary percutaneous coronary intervention. Conclusion. Our examination demonstrates not only the need for a more searching study of the predictors of bleeding in long-lived patients with acute coronary syndrome, but also the development of a specific prognostic risk score scale of hemorrhagic complications, adapted for patients of this age group.


Key words

hemorrhagic complication; percutaneous coronary intervention; acute coronary syndrome; long-lived patients

Reference list

1. World Health Organisation. Url: http://www.who.int/healthinfo/global.


2. Federalnaya slyjba gosydarstvennoi statistiki. Elektronnii resyrs. URL.:http://www.gks.ru/wps/wcm/connect/rosstat_main/rosstat/ru/statistics/ population/healthcare/


Federal'naya sluzhba gosudarstvennoj statistiki. Elektronnyj resurs. URL.: http://www.gks.ru/wps/wcm/connect/rosstat_main/rosstat/ru/statistics/ population/healthcare/


3. Elliott W.J., Black H. Treatment of Hypertention in the Elderly. Am. J. Geriatr. Cardiol. 2002; 11(1):11-21.


4. Mozaffarian D., Benjamin E.J., Go A.S. et al. American Heart Association. Heart Disease and Stroke Statistics: 2016 Update. Circulation.2016; 133(4):447-454.


5. Bokeriya L.A. Serdechno-sosydistaya hiryrgiya - 2012.Moskva: Izd-vo NCSSH im. A.N. Bakyleva RAMN, 2013. - 187 s.


Bokeriya L.A. Serdechno-sosudistaya hirurgiya - 2012. Moskva: Izd-vo NCSSKH im. A.N. Bakuleva RAMN, 2013. - 187 s.


6. Kireev K.A., Fokin A.A., Kireeva T.S. i dr. Chreskojnie koronarnie vmeshatelstva pri ostrom infarkte miokarda y pacientov starshe 75 let. Sovremennaya medicina: aktyalnie voprosi: sb. st. po mater. LII-LIII mejdynar. naych.-prakt. konf. ? 2-3(47). - Novosibirsk: SibAK, 2016: 71-77.


Kireev K.A., Fokin A.A., Kireeva T.S. i dr. Chreskozhnye koronarnye vmeshatel'stva pri ostrom infarkte miokarda u pacientov starshe 75 let. Sovremennaya medicina: aktual'nye voprosy: sb. st. po mater. LII-LIII mezhdunar. nauch.-prakt. konf. ? 2-3(47). - Novosibirsk: SibAK, 2016:71-77.


7. Erlih A.D., Harchenko M. S., Barbarash O. L. i dr. Stepen priverjennosti k vipolneniu rykovodstv po lecheniu ostrogo koronarnogo sindroma v klinicheskoi praktike rossiiskih stacionarov i ishodi v period gospitalizacii (dannie registra «REKORD-2»). Kardiologiya. 2013; 1: 14-22.


Erlih A.D., Harchenko M. S., Barbarash O. L. i dr. Stepen' priverzhennosti k vypolneniyu rukovodstv po lecheniyu ostrogo koronarnogo sindroma v klinicheskoj praktike rossijskih stacionarov i iskhody v period gospitalizacii (dannye registra «REKORD-2»). Kardiologiya. 2013; 1:14-22.


8. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients with Coronary Artery Disease. available at: Journal of the American College of Cardiology. Url: http://content.onlinejacc.org/article.aspx?doi=10.1016/j.jacc.2016.03.513


9. Patel A.B., Quan H., Welsh R.et. al. Validity and utility of ICD-10 administrative health data for identifying ST- and non-ST-elevation myocardial infarction based on physician chart review. CMAJ. 2015; 3(4): 413-418.


10. Llaó I., Ariza-Solé A., Sanchis J., Alegre O. et al. Invasive strategy and frailty in very elderly patients with acute coronary syndromes. EuroIntervention. 2018; 14(3):336-342.


11. Timmer J.R., Ottervanger, M.J. de Boer et al. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial Primary Coronary Angioplasty vs Thrombolysis-2 Trialists Collaborators Group. Arch. Intern. Med. 2007; 167 (13):1353-1359.


12. Timmer J.R., Hoekstra M., Nijsten M.W. et al. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention. Circulation. 2011; 124 (6): 704-711.


13. Toleva O., Ibrahim Q., Brass N., Sookram S., Welsh R.et al. Treatment choices in elderly patients with ST: elevation myocardial infarction-insights from the Vital Heart Response registry. Open Heart. 2015; 24(2):1-7.


14. Wilgenhof A., Droogmans S., Sonck J. et al. How to measure quality of care in patients presenting with STEMI? A single-centre experience. Acta Cardiol. 2015; 70(1):1-11.


15. Raposeiras Roubín S., Abu-Assi E., Iglesias Álvarez D.. et al. Therapeutic strategy in patients with severe anemia admitted for non-ST-segment elevation acute coronary syndrome and prognostic impact. Rev. Esp. Cardiol. (Engl Ed). 2014; 67(12):1058-1069.


16. Ariza-Sole A., Guerrero C., Formiga F.et al. Global Geriatric Assessment and In-Hospital Bleeding Risk in Elderly Patients with Acute Coronary Syndromes: Insights from the LONGEVO-SCA Registry. Thromb. Haemost. 2018; 118(3):581-590.


17. Brendan J. Doyle., Ting H.H., Malcolm R. Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. JACC. Cardiovasc. Interv. 2008; 1(2): 202-209.


18. Ibanez V., Castañeda S., Martín-Martínez M.A., González-Juanatey C. et al. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project. Semin. Arthritis Rheum. 2015; 44(6):618-626.


19. Bach R.G., Cannon C.P., Weintraub W.S. et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann. Intern. Med. 2004; 141(3):186-195.


20. Ferri L.A., Piatti L., Grosseto D. et al. Therapeutic strategies in elderly patients with acute coronary syndromes. G. Ital. Cardiol. (Rome). 2018; 19(11): 640-647.


21. Electronic resource: https://medsoftpro.ru/kalkulyatory/skf.html


22. Kinnaird T.D., Stabile E., Mintz G.S., et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am. J. Cardiol. 2003; 92(8): 930-935.


23. Grodzinsky A., Arnold S.V., Wanget T.Y. al. Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy. Am. Heart J. 2016; 182:111-118.


24. Mehran R., Pocock S.J., Nikolsky E.et al. A risk score to predict bleeding in patients with acute coronary syndromes. J. Am. Coll. Cardiol. 2010; 55(23):2556-2566.


25. Subherwal S., Bach, A.Y. Chen et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation. 2009; 119 (14):1873-1882.